Point prevalence survey of antibiotic use among hospitalized patients across 41 hospitals in Thailand

Author:

Anugulruengkitt Suvaporn12ORCID,Charoenpong Lantharita3,Kulthanmanusorn Anond4,Thienthong Varaporn5,Usayaporn Sang6,Kaewkhankhaeng Wanwisa4,Rueangna Oranat4,Sophonphan Jiratchaya7,Moolasart Visal3,Manosuthi Weerawat3,Tangcharoensathien Viroj4

Affiliation:

1. Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand

2. Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University , Bangkok , Thailand

3. Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health , Nonthaburi , Thailand

4. International Health Policy Program, Ministry of Public Health , Nonthaburi , Thailand

5. Division of International Disease Control Ports and Quarantine, Department of Disease Control, Ministry of Public Health , Nonthaburi , Thailand

6. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University , Bangkok , Thailand

7. The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), the Thai Red Cross AIDS Research Centre , Bangkok , Thailand

Abstract

Abstract Objectives To describe the antibiotic use among hospitalized patients in Thailand. Methods A standardized cross-sectional point prevalence survey (PPS) modified from the WHO PPS protocol was conducted in 41 selected hospitals in Thailand. All inpatients who received an antibiotic at 9 a.m. on the survey date were enrolled. The total number of inpatients on that day was the denominator. Results Between March and May 2021, a total of 8958 inpatients were enumerated; 4745 inpatients received antibiotics on the day of the survey and there were 6619 prescriptions of antibiotics. The prevalence of antibiotic use was 53.0% (95% CI 51.1%–54.0%), ranging from 14.3% to 73.4%. The antibiotic use was highest among adults aged >65 years (57.1%; 95% CI 55.3%–58.9%). From 6619 antibiotics prescribed, 68.6% were used to treat infection, 26.7% for prophylaxis and 4.7% for other or unknown indications. Overall, the top three commonly used antibiotics were third-generation cephalosporins (1993; 30.1%), followed by first-generation cephalosporins (737; 11.1%) and carbapenems (703; 10.6%). The most frequently used antibiotics for community-acquired infections were third-generation cephalosporins (36.8%), followed by β-lactam/β-lactamase inhibitors (11.8%) and carbapenems (11.3%) whereas for the patients with hospital-acquired infections, the most common antibiotics used were carbapenems (32.7%), followed by β-lactam/β-lactamase inhibitors (15.7%), third-generation cephalosporins (11.7%) and colistin (11.7%). The first-generation cephalosporins were the most commonly used antibiotics (37.7%) for surgical prophylaxis. Seventy percent of the patients received surgical prophylaxis for more than 1 day post surgery. Conclusions The prevalence of antibiotic use among hospitalized patients in Thailand is high and one-quarter of these antibiotics were used for prophylaxis. The majority of surgical prophylaxis was inappropriately used for a long duration post operation. Therefore, it is recommended that local guidelines should be developed and implemented.

Publisher

Oxford University Press (OUP)

Subject

Microbiology (medical),Infectious Diseases,Immunology and Allergy,Microbiology,Immunology

Reference38 articles.

1. Health and economic impacts of antimicrobial resistant infections in Thailand: a preliminary study;Phumart;J Health Sys Res,2012

2. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey;Versporten;Lancet Glob Health,2018

3. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys;Willemsen;Antimicrob Agents Chemother,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3